SUMMARY The clinical and neuroendocrine response to diuretic treatment was assessed at rest and on exercise in 12 patients with heart failure. Before treatment all patients were limited by breathlessness on exercise; one was oedematous. Plasma renin activity and aldosterone were normal but plasma noradrenaline was raised both at rest and on exercise. After one month's treatment with frusemide (40 mg) and amiloride (5 mg) weight was significantly reduced by a mean of 3-5 kg and exercise capacity had doubled. Plasma noradrenaline fell to normal at rest but remained abnormally raised on exercise. Plasma renin activity and aldosterone increased significantly both at rest and on exercise.
Diuretics bring about a considerable clinical improvement in patients with chronic heart failure but they stimulate the renin-angiotensin system. Activation of the renin-angiotensin system in moderate heart failure occurs as a response to diuretic treatment rather than as a result of the disease process itself.
Although diuretics are widely used in the treatment of chronic heart failure, the initial effects of treatment have rarely been studied. In recent years the importance of the neuroendocrine response to heart failure has been emphasised and many trials have been undertaken with drugs that oppose activation of the sympathetic and renin-angiotensin systems. Angiotensin converting enzyme (ACE) inhibitors in particular have been shown to be beneficial in patients with moderate to severe heart failure already treated with diuretics.1 Diuretics are known to activate the renin-angiotensin system; so a raised renin activity in patients with heart failure may be a consequence of treatment rather than of heart failure itself. The benefit of ACE inhibitors may occur partly because these drugs offset this effect of diuretics.
We have studied untreated patients presenting with breathlessness due to chronic heart failure and have assessed clinical and neuroendocrine variables at rest and on upright exercise before and one month after the introduction of diuretics (frusemide and Requests for reprints to Professor P A Poole-Wilson, Cardiothoracic Institute, 2 Beaumont Street, London WlN 2DX.
Accepted for publication 15 September 1986 amiloride). The purpose of the study was to determine whether neuroendocrine systems were activated in untreated heart failure or whether activation was secondary to treatment.
Patients and methods
Twelve patients (mean age 59 years (range 22-75), five female) were studied. Venous blood for neuroendocrine measurements was taken into chilled tubes, centrifuged immediately, and the plasma stored at -70°C until assay. Plasma renin activity and aldosterone were measured by radioimmunoassay,3 4 (normal range 0-5-2-5ng/ml/h (0 39-1-9nmol/l/h) and 100-600 pmol/l, respectively). Plasma (table and fig 4) . The reduction in resting heart rate during diuretic treatment correlated with the reduction in resting plasma noradrenaline (r = 0-64, p = group.bmj.com on December 30, 2017 -Published by http://heart.bmj.com/ Downloaded from Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics dosterone was increased by diuretic treatment in this patient.
Discussion
In an early study of the hormonal response to chronic heart failure, Brown et al found that nine out of 13 patients with untreated left ventricular failure had normal or low plasma renin activity at rest.6 Our study provides further evidence that not all untreated patients in heart failure have raised plasma renin activity or aldosterone concentrations at rest. We have also shown that the stimulus of maximal upright exercise causes only a modest increase in these hormones.
It is probable that the untreated patients in the present study had expanded circulatory volumes, as suggested by elevation of the venous pressure in four, peripheral oedema in one, and a loss of weight of more than 3 kg on treatment. In the presence of such circulatory expansion the finding of values for plasma renin activity at the upper end of the normal range does suggest some activation of this system. The present patients had only "moderate heart failure". In more severe untreated heart failure it is possible that activation of the renin-angiotensin system might be greater, but most previous studies showing significant activation of the renin-aldosterone system in heart failure are difficult to interpret as they have been undertaken in patients who not only had severe heart failure but were also being treated with diuretics. In such cases, raised concentrations of plasma renin and aldosterone could be due to the heart failure itself, to diuretic treatment, or to both.
In the present study plasma noradrenaline was raised both at rest and on exercise in untreated patients. Activation of the sympathetic system, as assessed by plasma noradrenaline concentration, appears to relate to the degree of left ventricular dysfunction in heart failure.7 8 In our patients with "moderate" heart failure the increase in plasma noradrenaline was not associated with an increase of plasma renin activity, suggesting that the earliest neuroendocrine response to heart failure is activation of the sympathetic system alone.
Diuretic The present study has shown that the introduction of frusemide with amiloride in patients with untreated heart failure caused a pronounced increase in plasma renin activity and aldosterone at rest and on exercise. Despite this stimulation of the reninangiotensin-aldosterone system there was clinical improvement and an increase in exercise capacity over a period of one month. Clinical improvement was associated with a reduction in sympathetic activity and plasma noradrenaline at rest but not on exercise.
Our study is complementary to that of Stampfer et a19 on the effects of thiazide diuretics in heart failure. Although we did not make haemodynamic measurements, it is likely that the haemodynamic effects of treatment were similar to those reported by failure treated with diuretics. An alternative explanation for the increase in exercise capacity would be that despite an overall reduction in cardiac output, the diuresis brought about a greater fall in arteriolar resistance in skeletal muscle on exercise and thus increased muscle blood flow.
These results have an important clinical implication. It is possible that a further increase in exercise capacity might have been achieved in these untreated patients if an angiotensin converting enzyme inhibitor had been prescribed with the diuretic to limit the increase of renin activity. Prevention of the diuretic induced stimulation of the renin-angiotensin system may be important in the long term management of chronic heart failure, since stimulation of the renin-angiotensin system, causing vasoconstriction and fluid retention, is deleterious to the failing heart and circulation. '8 19 22 Bayliss, Norell, Canepa-Anson, Sutton, Poole-Wilson
The obvious clinical benefits of diuretics in chronic heart failure may mask more subtle, possibly adverse, neuroendocrine changes, which may have important long term consequences in the progression of the disease process itself.
